MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Handwriting Based Screening of Parkinson’s Disease Using Image Analysis of Drawing Tasks

    A. Shih, L. Cruz-Mondragon, V. Santini, S. Panchawagh (Winston-Salem, USA)

    Objective: To evaluate whether image-based analysis of handwriting drawing tasks can distinguish Parkinson's disease from healthy controls. Background: Fine motor impairment is a core feature…
  • 2026 International Congress

    The Correlation Between Serum Uric Acid Levels And The Severity Of Parkinson’s Disease

    D. Prihananti, E. Pasmanasari (Semarang, Indonesia)

    Objective: This study aims to analyze the correlation between serum uric acid levels and the severity of Parkinson's disease. Background: Uric acid has been implicated…
  • 2026 International Congress

    An artificial intelligence-based model to predict Parkinson’s disease risk: the AI-PRA study protocol.

    SV. Virameteekul, S. Hadjidimitriou, I. Gerasimou, C. Sotirakis, L. Hadjileontiadis, M. Almarcha-Menargues, B. Falkenburger, O. Sánchez-Soliño, K. Michailidou, M. Zanti, P. Chairta, K. Christodoulou, M. Kurtis, M. Fabbri, N. Del Campo, A. Noyce, E. de Pablo-Fernández (London, United Kingdom)

    Objective: To present the protocol of the Artificial Intelligence-based Parkinson’s Risk Assessment (AI-PRA) study which aims to validate a novel personalised PD risk prediction model…
  • 2026 International Congress

    The Impact of Delaying Subcutaneous Device-Aided Therapy for Patients with Advanced Parkinson’s Disease

    R. Wiggins, J. Lee, T. Boodhna, O. Yip, J. Homola, L. Pronk, R. van Den Puttelaar, J. Aldred (Charlotte, USA)

    Objective: This study aims to evaluate the clinical, humanistic, and societal impact of delayed SC therapy in patients with PD. Background: As Parkinson’s disease (PD)…
  • 2026 International Congress

    Changes in Continuous Good ON and Best ON Time During the Waking Day With Tavapadon in People With Parkinson’s Disease

    R. Hauser, R. Dhall, D. Kremens, L. Harmer, K. Chan, J. Ma (Tampa, USA)

    Objective: To evaluate motor states throughout the waking day when tavapadon is added to oral carbidopa/levodopa in adults with Parkinson’s disease (PD) experiencing motor fluctuations.…
  • 2026 International Congress

    Medication Burden and Associated Challenges for People with Parkinson’s: A Survey of 359 UK Patients

    S. Jones, D. van Wamelen, S. Chapman, J. Patel (London, United Kingdom)

    Objective: To quantify medication burden among people with Parkinson’s disease (PD) and explore factors which contribute to medication experience in PD. Background: Individualised, complex medication…
  • 2026 International Congress

    Telerehabilitation Versus Conventional Therapy in Parkinson’s Disease: Evidence from Randomized Controlled Trials

    A. Fornari Caprara, J. Pitton Rissardo, J. Patino, A. Mcgarry, I. Walker (Camden, USA)

    Objective: To compare the effects of telerehabilitation and conventional rehabilitation on motor function and quality of life (QoL) in patients with Parkinson’s disease (PD). Background:…
  • 2026 International Congress

    Cerebellar Network Compensation in Parkinson’s Disease: Functional Connectivity Across Motor and Cognitive Circuits

    C. Lin, T. Magalhães, S. Yonce, I. Rampalli, R. Mahabir, J. Bernard (Houston, USA)

    Objective: To investigate whether alterations in cerebellar connectivity with cortical and basal ganglia networks in Parkinson’s disease (PD) represent compensatory network adaptations related to dopaminergic…
  • 2026 International Congress

    Kinetic–rest tremor polarity for differentiating dystonic tremor and Parkinson’s disease

    T. Tsuboi, T. Uematsu, M. Hashida, Y. Ito, K. Sawada, M. Higuchi, T. Ishizaki, T. Tsugawa, S. Maesawa, K. Fuse, Y. Saito, T. Fukushima, D. Tamakoshi, K. Hiraga, M. Suzuki, R. Saito, M. Katsuno (Nagoya, Japan)

    Objective: To characterize ordinal patterns of tremor amplitude across rest, postural, and kinetic conditions in dystonic tremor (DT) and Parkinson's disease (PD) using accelerometry, and…
  • 2026 International Congress

    An Ongoing Phase 1/2, Multi-center, Open Label Study of NouvNeu001 for the Treatment of Advanced Parkinson’s Disease

    M. Cai, J. Wei, X. Ren, R. Yan, H. Chen, N. Xiong (Chengdu, China)

    Objective: This ongoing, phase 1/2, multi-center, open label study aims to evaluate the safety, tolerability, and efficacy of NouvNeu001 (NCT#06167681) for treating mid to late-stage…
  • « Previous Page
  • 1
  • …
  • 72
  • 73
  • 74
  • 75
  • 76
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley